The majority of people with Parkinson's disease incur Freezing of Gait (FoG), which is not addressed adequately by medication. Cueing is a proven strategy to overcome FoG. The Cue2Walk is a device with automated detection of FoG and provision of rhythmic cues. In this study, the (cost-)effectiveness of the Cue2Walk device as compared to usual care is investigated.
Diagnosis of Parkinson's disease according to UK Brain bank criteria
Daily Freezing of Gait
Hoehn-Yahr stage 2-4
Stable medication regime and/or DBS settings as determined by the treating neurologist
Participation in another clinical study
Use of a personal cueing device at home
Previous use of the Cue2Walk medical device
Presence of co-morbidities that would hamper participation
Amsterdam UMC, location VUmc
Lead sponsor
Radboud University Medical Center
Collaborator